Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Treasury Shares (2017 - 2025)

Niagen Bioscience (NAGE) has disclosed Treasury Shares for 9 consecutive years, with $167000.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed 0.0% to $167000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $167000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $167000.0 for FY2025, 0.0% changed from the prior year.
  • Treasury Shares for Q4 2025 was $167000.0 at Niagen Bioscience, down from $1.5 million in the prior quarter.
  • The five-year high for Treasury Shares was $1.5 million in Q3 2025, with the low at $167000.0 in Q4 2024.
  • Average Treasury Shares over 4 years is $590250.0, with a median of $633000.0 recorded in 2023.
  • The sharpest move saw Treasury Shares soared 221.86% in 2023, then plummeted 71.65% in 2024.
  • Over 4 years, Treasury Shares stood at $183000.0 in 2022, then skyrocketed by 221.86% to $589000.0 in 2023, then tumbled by 71.65% to $167000.0 in 2024, then changed by 0.0% to $167000.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $167000.0, $1.5 million, and $301000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.